Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Suresh Durgam,1 Ronald P Landbloom,2 Mary Mackle,2 Xiao Wu,1 Maju Mathews,3 Henry A Nasrallah4 1Allergan Inc, Jersey City, 2Merck, Whitehouse Station, 3Forest Research Institute (now Allergan), Jersey City, NJ, 4Saint Louis University School of Medicine, St Louis, MO, USA Purpose: The primary obje...

Full description

Saved in:
Bibliographic Details
Main Authors: Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
asenapine
schizophrenia
long-term
safety
weight
olanzapine
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/61d88f1532d9409397d0f30c92e39abd
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/61d88f1532d9409397d0f30c92e39abd

Similar Items